BRAF突变癌症,结直肠癌,瘤相关淋巴结结构和免疫微环境研究:MAPK蛋白激酶分子作用和SIRPG-CD47蛋白信号通路研究
Hao Zhang1, Nenglin Zhang2, Xiaodi Yang1
1Department of Oncology, Minhang Hospital, Fudan University, Shanghai 201199, China.
International journal of biological macromolecules
|March 18, 2025
概括
结直肠癌 (CRC) 中的BRAF突变破坏了与瘤相关的淋巴结结构,并损害了免疫细胞的功能. 这会通过改变瘤免疫微环境,影响患者的预后.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- BRAF突变是结直肠癌 (CRC) 发展的关键驱动因素.
- 瘤相关淋巴结 (TLS) 是抗瘤免疫反应的关键部位.
- 了解BRAF突变如何影响TLS对于预测CRC进展至关重要.
研究的目的:
- 研究BRAF基因突变对结直肠癌免疫微环境重塑的影响.
- 具体评估BRAF突变对瘤相关淋巴结 (TLS) 成熟和功能的影响.
主要方法:
- 使用单细胞RNA测序对临床CRC患者样本的分析.
- 伪时空和空间转录组分析以探索细胞间通信.
- 免疫组织化学和多重光染色以评估TLS分布和成熟度.
- 统计分析以将发现与患者预后相关联.
主要成果:
- BRAF突变显著改变了瘤微环境中的TLS的数量和成熟度.
- 在CRC中,BRAF突变与患者预后有负相关性.
- 包括CD4+CXCL13细胞在内的T细胞子集的变化会影响TLS成熟.
- 在BRAF突变的CRC中观察到B细胞亚群中的功能缺陷,进一步重塑免疫格局.
结论:
- BRAF突变对结直肠癌免疫微环境产生深远的影响,特别是影响TLS.
- 与BRAF突变相关的TLS和免疫细胞功能的观察到的改变导致患者预后较差.
- 准BRAF突变途径可能提供治疗策略,以恢复CRC中的抗瘤免疫力.
关键词:
这种BRAF突变是BRAF突变.结肠直肠癌是一种癌症.免疫微环境是一个微环境.淋巴结结构 淋巴结结构在MAPK蛋白质激酶中,蛋白质激酶分子作用的分子作用.蛋白质信号通路是蛋白质的信号通路.在SIRPG-CD47中使用SIRPG.与瘤有关的瘤.更多相关视频
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
2.9K
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
910
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
